The Editor-in-Chief of AMB Express has officially retracted a 2020 article investigating the anticancer effects of maslinic acid in human neuroblastoma cells. The retraction note, published on 25 August 2026, states that the decision was made due to significant concerns regarding the reliability of the data presented in the original publication. The original article, titled “Maslinic acid induces anticancer effects in human neuroblastoma cells mediated via apoptosis induction and caspase activation, inhibition of cell migration and invasion and targeting MAPK/ERK signaling pathway,” was published on 1 June 2020 in Volume 10, article number 104 of the journal.
The retraction specifically cites issues with several figures in the original manuscript, indicating that sections of the images appear to be similar to other panels within the same article or to figures from other published works after rotations and changes in scale. The publisher noted that the Editor-in-Chief no longer has confidence in the reliability of the data reported in the article as a result of these irregularities.
In Figure 3, sections of the 0 µM and 10 µM panels appear to be similar after a rotation and change in scale. In Figure 4, sections of all panels appear to be similar to Figure 2 of a cited reference and Figure 2A of another reference, after rotations and changes in scale.
Figure 5 also drew scrutiny, with the 10 µM, 40 µM, and 80 µM panels appearing similar to Figure 4 of one reference and Figure 5 of another, following changes in scale.
Figure 8 exhibits similar issues, where the 0 µM, 40 µM, and 80 µM panels appear similar to Figure 9 of two different references and Figure 4A of a third, after changes in scale. Additionally, sections of the 0 µM and 10 µM panels in Figure 8 appear similar to each other after a change in scale. Figure 9 shows that the 40 µM panel appears similar to a panel of Figure 4B of another reference after rotation and a change in scale, while sections of the 0 µM and 10 µM panels also appear similar. These specific technical observations form the basis for the retraction decision.
The authors of the original article provided some source data upon request from the publisher. However, the retraction note states that this data was insufficient to address the concerns raised by the Editor-in-Chief.
Furthermore, the retraction note highlights that the authors have not responded to any correspondence from the publisher regarding this retraction.
Subject of Research: Retraction of a 2020 article on maslinic acid in neuroblastoma cells due to figure integrity concerns
Article Title: Retraction Note: Maslinic acid induces anticancer effects in human neuroblastoma cells mediated via apoptosis induction and caspase activation, inhibition of cell migration and invasion and targeting MAPK/ERK signaling pathway
Article References: Liu, Y., Lu, H., Dong, Q., Hao, X., & Qiao, L. (2026). Retraction Note: Maslinic acid induces anticancer effects in human neuroblastoma cells mediated via apoptosis induction and caspase activation, inhibition of cell migration and invasion and targeting MAPK/ERK signaling pathway. AMB Express, 16(1), Article 87. https://doi.org/10.1186/s13568-026-02107-4
Image Credits: AI Generated
DOI: 10.1186/s13568-026-02107-4
Keywords: retraction, maslinic acid, neuroblastoma, AMB Express, figure integrity, scientific misconduct, data reliability, cancer research, Note, Maslinic, acid, induces
News Source: Gregory Coleman. (November 8, 2026). Maslinic acid neuroblastoma study retracted over figure concerns. Scienmag.



